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Abstract
Introduction Intensive care unit (ICU) costs account for up to
20% of a hospital's costs. We aimed to analyse the individual
patient-related cost of intensive care at various hospital levels
and for different groups of disease.
Methods Data from 51 ICUs all over Germany (15 primary care
hospitals and 14 general care hospitals, 10 maximal care
hospitals and 12 focused care hospitals) were collected in an
observational, cross-sectional, one-day point prevalence study
by two external study physicians (January–October 2003). All
ICU patients (length of stay > 24 hours) treated on the study day
were included. The reason for admission, severity of illness,
surgical/diagnostic procedures, resource consumption, ICU/
hospital length of stay, outcome and ICU staffing structure were
documented.
Results Altogether 453 patients were included. ICU (hospital)
mortality was 12.1% (15.7%). The reason for admission and the
severity of illness differed between the hospital levels of care,
with a higher amount of unscheduled surgical procedures and
patients needing mechanical ventilation in maximal care hospital
and focused care hospital facilities. The mean total costs per
day were €791 ± 305 (primary care hospitals, €685 ± 234;
general care hospitals, €672 ± 199; focused care hospitals,
€816 ± 363; maximal care hospitals, €923 ± 306), with the
highest cost in septic patients (€1,090 ± 422). Differences
were associated with staffing, the amount of prescribed drugs/
blood products and diagnostic procedures.
Conclusion The reason for admission, the severity of illness and
the occurrence of severe sepsis are directly related to the level
of ICU cost. A high fraction of costs result from staffing (up to
62%). Specialized and maximum care hospitals treat a higher
proportion of the more severely ill and most expensive patients.
Introduction
Intensive care units (ICUs) currently represent the largest clin-
ical cost centres in hospitals, with expenses estimated to
reach up to 20% of a hospital's budget [1]. The total cost per
ICU patient highly depends on the severity of illness and the
length of the ICU stay [2-5]. Complications and the need for
prolonged mechanical ventilation lead to an increase in diag-
nostic procedures, invasive monitoring and the amount of
drugs and blood products, and thus lead to an increase of the
daily cost per patient [2,3,5-10]. The prolonged length of stay
in this resource and the personnel-intensive environment
results in overall costs that, for example, in septic patients are
two-fold to 11-fold higher compared with the general cost per
patient [5,9,11,12]. Costs for personnel make up 30–69% of
the total cost per patient [11,13-20]. Besides the high impact
of fixed personnel and overhead costs, direct variable costs
are very important to consider in order to understand the cost
of an ICU patient. Depending on the therapeutic andPage 1 of 10
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vary a lot [21-25]. Knowing the cost of what we prescribe
[26,27] might lead to a more rational but not restricted inten-
sive care [28] and is the basis for studies on cost-effective-
ness [29,30].
Despite the need for cost data, there are still few investiga-
tions on the real costs of intensive care therapy based on the
individual patient's resource usage [21,22,25,31,32]. Moreo-
ver, the comparison of studies on the cost of ICU care is often
difficult due to the use of varying methods of cost calculation
[30,33,34]. Many studies are based on ICU annual expendi-
tures or budgets, from which the costs are broken down for
the patient numbers and the days spent in the ICU [15,35-38],
charges [6,39] or cost-to-charge ratios [6,10,40-42] to ana-
lyse the cost of ICU care. Furthermore, most of these studies
were performed in university hospitals or maximal care facili-
ties and only a few investigations include hospitals of a lower
level of care [17,20,43,44]. To our knowledge there are no
studies directly comparing the costs of intensive care from
hospitals of different levels of care.
The present study, endorsed by the German Interdisciplinary
Association of Critical Care Medicine (DIVI), was performed
by visiting a nationwide randomly selected representative sam-
ple of ICUs from various hospital levels of care. The study is a
one-day cross-sectional survey, collecting data on all patients
with a length of stay > 24 hours who were treated in the ICU.
Based on these data we aimed to obtain detailed information
on the costs of intensive care in German ICUs from different
levels of hospital care. Part of the data obtained was pre-
sented at the congress of the European Society of Intensive
Care Medicine in 2004 [45].
Methods
After written consent from the hospitals' administration and
from the head of the ICUs to take part in our study and with
local ethics committee approval, two independent interviewers
visited 51 representatively selected ICUs in hospitals all over
Germany between January and October 2003. Hospital selec-
tion was based on a nationwide prevalence study on sepsis
performed by the German Competence Network Sepsis, for
which a representative hospital sample was randomly selected
from the registry of German hospitals and stratified by size
[46]. From this larger study sample (454 ICUs in 310 hospitals
out of 2,075 ICUs in 1,380 hospitals) a smaller sample of 51
ICUs, representing 2.5% of all ICUs in Germany, was ran-
domly selected by the German Competence Network Sepsis
administration. Four ICUs refused to take part in the study and
thus were replaced by further randomly chosen ICUs accord-
ing to their hospital size.
The ICUs included were defined by four levels of hospital care
(Table 1). The allocation of hospital levels is based on the gov-
ernmental mandate of medical care provision and mainly dif-
fers in terms of medical specialties and of diagnostic and
therapeutic possibilities provided.
Primary care hospitals (pcH) contribute to the primary health-
care in the very local area and provide the 'basic' specialties
such as surgery and/or internal medicine; in addition, pcH
often offer other specialties (for example, gynaecology and
obstetrics).
General care hospitals (gcH) provide care for a broader area.
Besides internal medicine and surgery, these hospitals may –
based on governmental requirements planning – also house
specialties such as gynaecology and obstetrics, ear, nose and
throat, ophthalmology and, eventually, orthopaedics, urology,
radiology and laboratory services.
Focus care hospitals (fcH) assure healthcare on a regional
level. In contrast to gcH facilities, they may also include depart-
ments such as neurology, paediatrics, or psychiatry. Accord-
ing to the requirements they may provide very focused care
(for example, heart or thoracic surgery).
Maximum care hospitals (mcH) provide highly differentiated
diagnostic and therapeutic possibilities (for example, compu-
ter tomography, magnetic resonance tomography). University
hospitals are generally maximum care hospitals.
Sorted by category, the present study included 14 surgical
ICUs, five nonsurgical ICUs, 28 interdisciplinary ICUs and four
special ICUs.
Data collected
Structural ICU data (such as the number of ICU beds, ICU
staffing) and hospital data (such as the number of hospital
beds and hotel cost) were collected by interviewing the head
of the ICU, the head of the hospital's administration and the
assigned ICU physician.
We included all adult patients with a length of ICU stay ≥ 24
hours who were treated in the selected ICU on the day of the
analysis. Clinical and resource use data were collected on a
cross-sectional (one-day) basis by analysing the patient
records and by interviewing the nurses and physicians
involved in the treatment of the patient.
Resource data included the complete ICU therapy (every drug,
invasive procedures, blood and blood products and fluid ther-
apy), the usage of disposables (drainages, dressings, and so
on) and diagnostic procedures such as X-ray scan, computed
tomography scan, laboratory testing and microbiological anal-
ysis. The clinical patient data collected consisted of age, sex,
reason for admission, diagnosis, comorbidities and type of
patient (nonsurgical, scheduled surgery, unscheduled sur-
gery). The severity of illness, measured by the Simplified Acute
Physiology II (SAPS II) score, the System Organ FailurePage 2 of 10
(page number not for citation purposes)
Available online http://ccforum.com/content/11/3/R69Assessment (SOFA) score and the existence of sepsis, as well
as the workload (by the Therapeutic Intervention Scoring Sys-
tem (TISS)-28) were determined by the visiting physician for
the day of the analysis. After the initial visits, the ICUs were
later contacted by telephone to obtain follow-up information
(total length of ICU stay and hospital stay, and ICU/hospital
survival) of the selected patients. After this second contact, a
list of the assessed resources was sent to the hospitals with a
request to provide the hospital-specific (purchasing) prices
and costs.
Cost calculation
The cost perspective of this study was the selected ICU from
the hospital's point of view combining two approaches to
obtain the individual patient's specific costs.
Variable cost
For every patient, all resources used on the visiting day
(excluding staff time) – that is, the type and frequency of given
drugs and consumables (syringes, catheters, and so on) as
well as laboratory and microbiological analyses and diagnostic
procedures – were assessed on an individual basis. Proce-
dures outside the ICU (for example, surgical interventions) on
the day of analysis were not taken into account, except for X-
ray scans, computed tomography scans, and so forth.
The direct variable costs were calculated based on a specific
cost catalogue for the whole ICU sample using the following
approach. Prior to the study, items needed for complex proce-
dures – for example, the insertion of a venous access (venous
catheter, gloves, swab, and so on) – were defined at the ICU
in Göttingen. Actual hospital purchasing costs for drugs, dis-
posables, nutrition, and blood products were collected in a
hospital-specific cost catalogue. Per-package costs were
transformed into unit costs when necessary. Due to the fact
that not every one of the 51 hospitals was able to provide
detailed information on every single item, a general cost cata-
logue was established and used for cost calculation. Effective
costs of laboratory and microbiologic analysis were generally
not available (only the much higher official tariffs). For these
items, the detailed information of effective costs from the Uni-
versity hospital of Göttingen was used under the assumption
that existing cost differences between institutions are negligi-
ble. Costs per patient resulted from multiplying the mean
prices (from the cost catalogue) by the frequencies and dos-
ages of resources used for the individual patients derived from
the assessed data.
Table 1
Type of hospital, size and number of included patients (n = 453)
Hospital category 
(type of care)
Hospitals (n) Hospital size 
(number of beds)
Number included (n) Intensive care unit size 
(number of beds)
Intensive care units (n) Included patients (n)
Primary care 15 0–200 8 0–5 2 93 (20.5%)
201–500 7 6–10 12
501–1'000 0 11–15 1
>1'000 0 16–20 0
>20 0
General care 14 0–200 4 0–5 1 103 (22.7%)
201–500 10 6–10 11
501–1'000 0 11–15 2
>1'000 0 16–20 0
>20 0
Maximum care 11 0–200 0 0–5 0 146 (32.3%)
201–500 1 6–10 3
501–1'000 5 11–15 6
>1'000 5 16–20 1
>20 1
Focus care 11 0–200 2 0–5 0 111 (24.5%)
201–500 5 6–10 5
501–1'000 4 11–15 3
>1'000 0 16–20 3
>20 0Page 3 of 10
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Intensive care staff costs per day of care were calculated for
each centre by multiplying the wages (based on gross income,
employer's contribution included) per hour by the data on staff
numbers, working hours, and ICU-related work percentages
on weekdays and weekends of the individual ICUs, obtaining
the mean local staff costs per day. Physicians for consultation
were not included as long as they were not part of the ICU
staff. Total fixed costs were allocated to the number of ICU
beds.
Basic bed costs per day ('hotel costs') include overhead costs
for nonclinical support services, maintenance, energy and hos-
pital administration. This information was derived from the hos-
pital administration. Equipment (such as monitors, ventilator,
and so on) and other investment costs as well as depreciation
were not included.
Total patient costs were obtained by adding up the calculated
direct variable cost and the fixed cost. All costs were gathered
and are presented in euros (for 2003).
Data analysis
Analysis of data was carried out using MS Access 97 and
Excel 7.0 (Microsoft Corporation, Redmond, WA, USA),
SPSS 11.0 and Clementine (classification and regression
algorithm trees: C4.5 and CART) (SPSS Inc., Chicago, IL,
USA) [47]. Differences in costs of subgroups, length of stay
(LOS), and mortality were tested statistically; for example,
using chi-squared statistics to identify optimal splits or using
CART methods, which are based on minimization of impurity
measures (for example, the Gini index). The Gini index is a
measure based on squared probabilities of membership for
each target category in the node [48]. The index reaches its
minimum (zero) when all cases in the node fall into a single tar-
get category. We applied Bonferroni adjustment to P values
when multiple tests were performed. We used this adjustment
to prevent the overall error rate from exceeding the nominal cri-
terion (alpha) due to multiple tests. Cost data are presented as
the mean with standard deviation, while clinical data are given




A total of 453 patients with a length of stay of ≥ 24 hours were
included; 35.8% (n = 162) were nonsurgical patients, 32.2%
(n = 146) were scheduled surgery patients, and 32% (n =
145) were patients with unscheduled surgery (Table 2). On
the day of assessment, 13.7% (n = 62) of the patients were
found to be severely septic, 41.7% were mechanically venti-
lated, and 4.2% received renal replacement therapy (Table 2).
The overall ICU mortality was 12.1% (n = 55). ICU mortality
tended to be higher in pcH patients (18.3%), but did not reach
significance. The type of admission differed (P < 0.0001)
between hospital levels, with the highest percentage of sched-
uled surgical patients being treated in fcH (49.6%) (Table 2).
The rate of unscheduled surgical procedures was highest in
mcH (37.7%) followed by gcH (34%). The pcH had the high-
est share of nonsurgical patients (59.1%).
The workload measured by TISS-28 was significantly higher in
mcH (median 33, 24 to 38) and fcH (median 27, 19 to 36)
compared with pcH (median 24, 16 to 30) and gcH (median
23, 18 to 29) (P < 0.0001) (Table 2). There were also
significant differences in frequencies of mechanical ventilation
between the hospital levels of care (P < 0.0001): 56.9% in
mcH, 47.8% in fcH, 24.3% in gcH, and 30.1% in pcH.
The ICU LOS and the hospital LOS differed significantly (P =
0.001) and was highest in fcH (median ICU LOS, 12 days;
hospital LOS, 29 days), while mcH (median ICU LOS, 6 days;
hospital LOS, 23 days), gcH (median ICU LOS, 4 days; hos-
pital LOS, 20 days), and pcH (median ICU LOS, 5 days; hos-
pital LOS, 19 days) only showed slight differences.
Severity of illness on the day of analysis, measured by SAPS II
and SOFA scores, was 32.0 (23 to 44) and 4.0 (2 to 6),
respectively. The SAPS II score and the SOFA score did not
differ substantially between hospital levels (Table 2).
There was a difference in the percentage of patients admitted
from other hospitals/ICUs, with the highest rate of transferred
patients in fcH (20.7%) (Table 2) but with only slightly higher
admission rates in mcH compared with gcH and pcH.
Between the different levels of care, the characteristics of
transfer patients differed significantly as shown by the severity
of illness SAPS II score (pcH, 39 (34 to 44); gcH, 33 (25 to
39); fcH, 29 (27 to 43); mcH, 47 (43 to 58); P = 0.0328).
ICU structure
The staffing structure of nurses did not differ between the dif-
ferent levels of hospital care (P = 0.732) with regard to the
nurse-to-bed ratio per shift (median, 0.37 (0.33 to 0.43);
mean, 0.39 ± 0.1). Staffing structure of physicians, however,
differed between the various levels of care. In the mcH ICUs
91% of ICU physicians spent 80 to 100% of their working
time in the ICU, with no other responsibilities for 73% of the
physicians. At the other hospital levels, the percentage of full-
time ICU physicians (80 to 100% of working time) was lower:
30% in pcH, 55% in gcH, and 55% in fcH.
Cost calculations
The mean total costs per patient and day were €791 ± 305.
Staff costs comprise the largest proportion of total costs at
around 56%, followed by medication costs (including blood
products, fluids, nutrition, drugs) at 18.7% (Table 3). The
mean cost per TISS point was €32 ± 13.7. The mean daily
cost in various subgroups of patients differed considerably.
Patients admitted for unscheduled surgery were more expen-Page 4 of 10
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320) or nonsurgical patients (€759 ± 277) (P = 0.004).
Patients on mechanical ventilation caused higher costs than
nonventilated patients (€946 ± 355 versus €680 ± 203; P <
0.0001). Septic patients had consistently higher daily costs
than nonseptic patients in all hospital levels of care, with an
average of €1,090 ± 422 versus €745 ± 255 (P < 0.0001).
Table 2
Patient data sorted by level of hospital care
All patients Primary care hospitals General care hospitals Focused care hospitals Maximum care hospitals
Patients (% (n)) 100 (453) 20.5 (93) 22.7 (103) 24.5 (111) 32.2 (146)
Age (years) (median (Q1–Q3)) 68 (56.8–76.0) 69.0 (60.0–78.0) 71.0 (58.0–78.5) 68.0 (60.0–75.5) 68.0 (53.3–73.0)
Gender (% (n))
Male 55.2 (250) 46.2 (43) 46.6 (48) 63.1 (70) 61.0 (89)
Female 44.8 (203) 53.8 (50) 53.4 (55) 36.9 (41) 39.0 (57)
Admission from (% (n))
Operation room 36.0 (163) 26.9 (25) 39.8 (41) 58.6 (65) 63.0 (92)
General ward 14.1 (64) 33.3 (31) 21.4 (22) 15.3 (17) 16.4 (24)
Emergency ward/ambulance 21.0 (95) 35.5 (33) 32.0 (33) 5.4 (6) 15.8 (23)
Other hospital/intensive care unit 8.4 (38) 4.3 (4) 3.9 (4) 20.7 (23) 4.8 (7)
Readmission 6,8 (31) 4.3 (4) 6.8 (7) 7.2 (8) 8.2 (12)
Reason for admission (% (n))
Nonsurgical 35.8 (162) 59.1 (55) 42.7 (44) 24.3 (27) 25.3 (37)
Surgical scheduled 32.2 (146) 12.9 (12) 23.3 (24) 49.6 (55) 37 (54)
Unscheduled surgery 32.0 (145) 28.0 (26) 34.0 (35) 26.1 (29) 37.7 (55)
Severity of illness (median (Q1–Q3))
SOFA score 4 (2–6) 3 (2–6) 3 (2–6) 3 (2.5–7) 4 (2–7)
SAPS II score 32 (23–44) 35 (23–46) 30 (20–40.5) 30 (21.5–44.5) 31 (25–45.8)
Workload, TISS score (median (Q1–Q3)) 27 (19–35) 23 (16–30) 24 (18–29) 27 (19–36) 33 (24–38)
High resource intensive (% (n))
Mechanical ventilation 41.7 (189) 30.1 (28) 24.3 (25) 47.8 (53) 56.9 (83)
Renal replacement therapy 4.2 (19) 1.1 (1) 1.9 (2) 5.4 (6) 6.9 (10)
Invasive proceduresa 52.5 (238) 46.2 (43) 43.7 (45) 56.8 (63) 59.6 (87)
Antibiotic/mycotic treatment 55.9 (253) 51.6 (48) 49.5 (51) 56.8 (63) 62.3 (91)
Blood products 13.7 (62) 10.8 (10) 10.7 (11) 17.1(19) 15.1 (22)
Diagnostic proceduresb 93.8 (425) 93.6 (87) 94.2 (97) 91 (101) 95.2 (139)
Length of stay (days) (median (Q1–Q3))
Intensive care unit 6 (2–18) 5 (2–11) 4 (1–9.5) 12 (3–26) 6 (2–19)
Hospital 22 (14–40) 19 (11–33) 20 (13.5–34) 29 (17–53) 23 (14–36.8)
Mortality (% (n))
Intensive care unit 12.1 (55) 18.3 (17) 6.8 (7) 10.8 (12) 13 (19)
Hospital 15.7 (71) 21.5 (20) 8.7 (9) 16.2 (18) 16.4 (24)
Data are presented as median values (25th (Q1) and 75th (Q3) percentiles) or percentages. SAPS, Score Simplified Acute Physiology, SOFA, System Organ Failure 
Assessment; TISS Therapeutic Intervention Scoring System (TISS-28).
aFor example, intubation, catheterizations, renal replacement therapy and mechanical ventilation.
bAll diagnostic procedures including imaging, laboratory tests and microbiologic analysis.Page 5 of 10
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SAPS II score < 47 (n = 363, €742 ± 252) versus SAPS II
score ≥ 47 (n = 90, €984 ± 410) (P < 0.0001). Organ failure
assessed by the SOFA score also showed a clear separation
of costs at SOFA score < 7 (n = 369, €728 ± 240) versus
SOFA score ≥ 7 (n = 84, €1,061 ± 402) (P < 0.0001).
Survivors were less expensive than nonsurvivors (€773 ± 291
versus 914 ± 369 per day; P = 0.012).
In 45 patients (10% of patients) representing the highest cost
group (upper 90th percentile), the mean daily cost was
€1,470 ± 308. The spectrum of these patients was mainly
represented by cases with unscheduled surgery (40%) that
were mostly mechanically ventilated (86.7%) and suffered
from sepsis (44.4%).
Comparison of costs between hospital levels of care
In general, mcH and fcH had significantly (P < 0.0001) higher
mean patient costs per day than smaller hospitals with primary
and general care (Table 3). Patients with long ICU LOS (>14
days) caused a significantly (P < 0.0001) higher daily cost
(€917 ± 392) compared with those with shorter ICU LOS
(€735 ± 241). In the group of long ICU LOS patients, the
mean daily cost also varied significantly between the different
levels of hospital care: €776 ± 210 in pcH, €793 ± 308 in
gcH, €865 ± 449 in fcH, and €1,089 ± 370 in mcH (P =
0.0019). Namely, 84.4% of the most expensive patients
(upper 90th percentile) were treated in mcH and fcH. The
higher expenditures are reflected by the difference in workload
(TISS) (Table 2), which was significantly higher in mcH (mean,
31.6) and fcH (mean, 27.3) (P < 0.0001). However, the calcu-
lation of the cost per TISS point revealed no significant differ-
ences (P = 1.000).
Within the small fraction of patients transferred from other
ICUs or hospitals (Table 2), those transferred to mcH caused
the highest daily cost (€1,051 ± 262) compared with the
other levels of care (pcH, €714 ± 299; gcH, €683 ± 144; fcH,
€621 ± 234) (P = 0.0021). The staff costs differed signifi-
cantly between the hospital levels of care (P < 0.0001) and
were the highest in mcH (Table 3). Significant differences
were also found in the expenditures for diagnostic procedures
(P < 0.0001), laboratory investigations (P < 0.0001), microbi-
ology (P = 0.0062), and for medication in general (P =
0.0088). The costs for blood products (P = 0.2054), invasive
procedures (P = 0.0785), and antibiotics (P = 0.3205) were
similar (Table 3).
Nonsurgical and special focus ICUs showed higher total daily
costs compared with surgical and interdisciplinary ICUs.
Discussion
The present study aimed to estimate the current situation in
German ICUs over all levels of care. This was achieved by vis-
iting 51 representatively selected ICUs across Germany, cov-
ering all types of care (general, basic, maximum, main focus).
Mean total intensive care expenditure per patient per day in
Germany was €791 ± 305, with 19.4% of the patients costing
more than €1,000 per day and a maximum of €2,815 per
patient-day. Studies from previous studies from different Euro-
pean countries found mean daily costs ranging between
€1.125 and €1.590 per day [14,16,31,32,35,36,49]. The
majority of these studies were performed in university or teach-
Table 3
Mean daily intensive care unit costs per patient and percentage of total cost sorted by hospital level of care
Direct cost (€) All hospitals (n = 
453)
Primary care hospitals 
(n = 93)
General care 
hospitals (n = 103)
Focused care 
hospitals (n = 111)
Maximum care 
hospitals (n = 146)
Mean daily cost 791 (305)* 685 (234) 672 (199) 816 (363) 923 (306)
€/TISS point 32 (13.7) 33 (14.8) 31 (11.6) 33 (15.0) 32(13.7)
Staff cost 444 (105)* 387 (54) 415 (93) 438 (114) 505 (101)
Medicationa 148 (191)* 139 (185) 98 (108) 169 (211) 174 (217)
Antibiotics 24 (43) 20 (36) 19 (38) 29 (48) 25 (46)
Blood products 30 (105) 16 (60) 16 (53) 43 (151) 39 (113)
Invasive proceduresb 24 (55) 14 (30) 20 (50) 30 (66) 30 (61)
Diagnosticsc 96 (90)* 76 (66) 67 (64) 102 (97) 122 (105)
Laboratory 65 (62)* 49 (40) 44 (37) 71 (67) 87 (75)
Microbiology 9 (30) 7 (25) 3 (8) 9 (27) 16 (41)
Data presented as the mean (standard deviation). TISS, Therapeutic Intervention Scoring System (TISS-28).
aAll given drugs, fluids, blood products and nutrition.
bFor example, intubation, catheterizations, renal replacement therapy and mechanical ventilation.
cAll diagnostic procedures including imaging, laboratory tests and microbiologic analysis.
*Significant difference (P < 0.05) between the different levels of hospital care.Page 6 of 10
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pare different levels of hospital care [17,22,35,43,49]. Taking
only university hospitals into account we found a mean cost of
€1.132, which is well in line with the abovementioned recent
findings. The overall lower mean daily cost of €791 compared
with these studies can therefore be easily explained by the
high number of hospitals of levels other than maximum care.
As shown in a number of studies, the severity of illness has a
huge impact on ICU cost [2,3,5-10,50]. In our study popula-
tion, 10% of all patients (45 patients; mean cost, €1,469) con-
sumed about 19% of the total resources. In all levels of care
the most expensive patients were those needing mechanical
ventilation, those patients having a high severity of illness and/
or severe sepsis as well as nonsurvivors. Patients admitted for
unscheduled surgical procedures (that is, emergency cases)
caused significantly increased cost.
In previous studies the following daily costs were found for
septic patients: €1,318 (in 2001 from three German teaching
hospitals) [5], and US$931 (in 1998 from one teaching hos-
pital in the United Kingdom) [11].
Overall there was no difference in SAPS and SOFA scores on
the study day between the hospital levels. We have to bear in
mind, however, that these scores were evaluated during inten-
sive care treatment. The lack of difference therefore only indi-
cates a more or less stable situation during the treatment in
general, not the primary severity of illness. Nonetheless, the
patients treated in mcH were obviously more severely ill than
those in smaller hospitals: cases needing mechanical ventila-
tion were nearly twice as frequent in mcH as in pcH, and renal
replacement therapies and other invasive procedures were
more frequent in mcH. Emergency cases with unscheduled
surgery requiring more intensive care interventions were also
more frequent in mcH. Consequently, the TISS was higher in
mcH and 84.4% of the most expensive patients (that is, the
upper 90th percentile of costs) were treated there. Prediction
of patients' average daily costs in intensive care, however, is
only scarcely linked to descriptive criteria. Only 33.6% of the
variation of daily costs (mean ± SD, €704 ± 422) in a mono-
centre analysis could be explained by criteria such as the
Acute Physiology and Chronic Health Evaluation II score, gen-
der, age, mechanical ventilation, emergency admission and
others [21].
Resource consumption and the use of diagnostic procedures
differed significantly between the hospital levels. Related to
the level of performance measured by the TISS-28, however,
the overall mean daily ICU cost per patient was €32.0/TISS
point with only minor differences between the hospital levels
(Table 3). This shows that mcH are not at all more expensive if
matched against the level of performance. This profile of daily
cost per TISS point is slightly less than the values of €34–37/
TISS recently evaluated from a single university ICU in Finland
[38] or of €36/TISS in Germany [16].
The differences between hospital categories are explained by
the allocation of various hospital responsibilities. This is
reflected by the patients transferred between hospitals of dif-
ferent levels of care. Patients transferred to maximum care
ICUs were more severely ill and more expensive compared
with those transferred to pcH or gcH. This partly confirms the
recent findings of Golestanian and coworkers, who showed
that patients transferred to tertiary care centre ICUs were
more severely ill and more expensive [51]. This reflects a com-
mon practice that patients who cannot be handled in primary
or general care facilities due to limited diagnostic or therapeu-
tic capabilities are usually transferred to fcH or mcH ICUs for
more effective treatment [52-54]. On the other hand, patients
who are successfully treated in fcH or mcH are often trans-
ferred back for further intensive care treatment in the lower
level hospitals, often due to the lack of local intermediate care
facilities.
The cost for staffing is the highest expenditure of intensive
care treatment, with 56.1% on average overall (Table 3). Staff-
ing of nurses is remarkably similar at all hospital levels. This is
a consequence of official regulations on staffing for nurses,
which is related to the number of intensive care beds. There
are, however, no such strict regulations for physicians. In gen-
eral, the larger ICUs in mcH are mostly run by full-time physi-
cians, whereas in smaller hospitals the ICU allocation of
physicians to the ICU is more reduced and they often have
additional tasks (for example, in the operating theatre). Conse-
quently, the mcH are burdened with the highest staffing cost.
To our knowledge this is the first study that compared the ICU
cost nationwide in intensive care in a representative sample of
51 ICUs by analysing the resource consumption on an individ-
ual patient level. It must be mentioned that this bottom-up
approach is very laborious and probably difficult to perform in
studies analysing cost in a larger number of ICUs over the ICU
stay. Alternatives such as cost blocks proposed Edbrooke and
colleges [17,24,33,55], cost analysis based on the therapeu-
tic score [16,44,56-58] or cost prediction models [59] might
be more applicable in daily practice. These methods should
only be considered after carefully testing for accuracy on a
national level, however, and are less reliable on the individual
patient basis [13]. With the increasing number of computer-
ized patient data management systems in the ICU, the analysis
of direct variable cost becomes easier [60]. Besides the rela-
tively large number of ICUs included in our study, there are fur-
ther strengths one could consider. The ICUs were included
based on a stratified random sampling strategy and the data
were collected by two dedicated intensivists visiting the ICUs
instead of sending out data sheets to collect probably inhomo-
geneous information.Page 7 of 10
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study was performed as a 1-day prevalence investigation that
may provide accurate actual information. Owing to this design,
however, we cannot draw conclusions on the total cost per
patient. Moreover, the quality of care provided or its effective-
ness cannot be estimated since important information on the
course of ICU therapy is lacking.
In our study we only included patients with an ICU LOS longer
than 24 hours. In Germany, an ICU's task within the hospital
differs highly between the different levels of care. In smaller
hospitals there are no intermediate care wards; therefore,
postoperative recovery supervision and care in pcH and gcH
is routinely provided by the ICUs. The higher level of personnel
costs in maximum care facilities is mainly caused by the fact
that critically ill patients are treated round the clock in maxi-
mum care ICUs.
ICUs are not only responsible for critically ill patients, however
– especially in gcH and pcH – but also take care of so-called
intermediate care patients. After regular working hours the
ICU staff takes care of postoperative recovery patients. To
avoid the inclusion of non-ICU patients, therefore, a LOS > 24
hours was defined as an inclusion criterion. We might there-
fore have missed extremely severely ill patients who died
within the first hours after admission.
Recent studies have shown that increasing the ICU size [43]
but also increasing the adequate ICU staffing can be consid-
ered cost-effective [61-63]. From our study it cannot be
deduced that the higher resource usage and higher fixed cost
in mcH may also be comparatively cost-effective in terms of
outcome improvement. Such presumptions should be avoided
because of differences in case mix between the hospital levels
of care and because of the one-day prevalence study design.
For this purpose, a matched-pairs study with comparable
patient groups analysed over the whole period of the ICU stay
is required.
For cost calculation, a cost catalogue based on averaged
resource information from the participating ICUs was used.
Owing to the confidentiality of such data, however, it was
impossible to collect complete specific cost information on
every item from each ICU. An averaged cost catalogue such
as we used, then, might underestimate some differences in
daily cost in such situations. For example, the purchasing price
for a venous canula may vary by about 40% between different
ICUs due to different brand and price conditions. Neverthe-
less, we suppose that the overall average cost catalogue may
provide a sufficient basis for general cost calculations.
Conclusion
The present study demonstrates that a considerable degree of
variation exists between ICUs according to the hospitals' level
of care. These differences are mainly caused by the case mix
and by the need to provide a higher level of resource con-
sumption for the cost of diagnostic procedures and of staffing
in mcH. There are common cost patterns for certain patient
groups independent of ICU or hospital categories, such as
those with unscheduled surgical procedures. The need for
prolonged mechanical ventilation as well as the occurrence of
sepsis results in significantly increased cost per day.
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Key messages
• A high fraction of costs result from staffing (56.1% on 
average overall).
• Reason for admission, severity of illness and the occur-
rence of severe sepsis are directly related to the level of 
ICU cost.
• The case mix and workload (reflected by TISS score) 
significantly differs between different levels of hospital 
care.
• Specialized hospitals and mcH treat a higher proportion 
of the most expensive patients.Page 8 of 10
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